Akadeum Life Sciences
2014
FOUNDED
PRIVATE
STATUS
1-10
EMPLOYEES
Series A
LATEST DEAL TYPE
$4M
LATEST DEAL AMOUNT
13
INVESTORS
Description
Developer of a two-parameter cell separation technology designed to facilitate the removal of target cells from biological samples. The company's technological product is based on buoyancy-activated cell sorting (BACS) that uses microscopic micro-bubbles to capture target cells and quickly float them to the surface of a liquid sample for removal, enabling medical practitioners to use those cells for performing downstream testing and analysis with increased efficiency.
Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Primary Office
- 674 South Wagner Road
- Ann Arbor, MI 48103
- United States
+1 (734) 000-0000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Akadeum Life Sciences’s full profile, request a free trial.
Akadeum Life Sciences Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Later Stage VC (Series A) | 19-Dec-2019 | $4M | 00.000 | 0000 | Completed | Generating Revenue |
| 6. Early Stage VC | 01-Feb-2019 | 000 | 00.000 | Completed | Generating Revenue | |
| 5. Seed Round | 28-Sep-2017 | 00.000 | 00.000 | 00.000 | Completed | Generating Revenue |
| 4. Seed Round | 31-Jul-2015 | 000 | 00.000 | 00.00 | Completed | Generating Revenue |
| 3. Seed Round | 21-Oct-2014 | 00000 | 00000 | Completed | Generating Revenue | |
| 2. Accelerator/Incubator | Completed | Startup | ||||
| 1. Grant | 01-Mar-2014 | $50K | Completed | Startup |
Akadeum Life Sciences Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|---|---|---|---|---|---|---|---|
| Series A | 00,000,000 | 00.000000 | 00.00 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
| Series A-1 | 0,000,000 | 00.000000 | 00.00 | 00.00 | 00.00 | 00 | 00.00 | 00 |
| Seed Prime | 5,393,132 | $0.001000 | $0.03 | $0.33 | $0.33 | 1x | $0.33 | 13.21% |
| Seed | 3,627,200 | $0.001000 | $0.02 | $0.29 | $0.29 | 1x | $0.29 | 8.89% |
Akadeum Life Sciences Competitors (19)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Cellular Dynamics International | Formerly VC-backed | Madison, WI | 000 | 00000 | 000000&0 | 00000 |
| 000000000 00000000 | Corporation | Carlsbad, CA | ||||
| 0000000000 0000000 | Pending Transaction (M&A) | Beit-Haemek, Israel | 000 | 0000 | 000000&0 | 0000 |
| 000000000 | Venture Capital-Backed | Cambridge, United Kingdom | 00 | 00.000 | 0000000000 0 | 00.000 |
| 000000000 | Formerly VC-backed | Yokohama, Japan | 000 | 000.00 | 00000000 | 000.00 |
Akadeum Life Sciences Investors (13)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| Berkeley Catalyst Fund | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| Genoa Ventures | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| BioInfleXion Point Partners | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| Hemisphere Ventures | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| Invest Detroit | Real Estate | Minority | 000 0000 | 000000 0 |
Akadeum Life Sciences Executive Team (6)
3 Former Executives
You’re viewing 3 of 6 executives. Get the full list »Akadeum Life Sciences Board Members (8)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| Brandon McNaughton Ph.D | Akadeum Life Sciences | Co-Founder, Chief Executive Officer & Board Member | 000 0000 | |
| Brock Siegel Ph.D | BioInfleXion Point Partners | Board Member | 000 0000 | |
| Douglas Neal | eLab Ventures | Board Member | 000 0000 | |
| George Dunbar Jr. | Akadeum Life Sciences | Board Member | 000 0000 | |
| John Younger | Akadeum Life Sciences | Co-Founder, Chief Science Officer & Board Member | 000 0000 |
1 Former Board Member
You’re viewing 5 of 8 board members. Get the full list »